Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Sementino

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Cancer Research|September 2, 2017
Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicityYinfei Tan, Eleonora Sementino, Jonathan Chernoff, et al.
Cancer Research|October 22, 2024
AKT and the Hallmarks of CancerEleonora Sementino, Dalal Hassan, Alfonso Bellacosa, et al.
Cancers|August 28, 2025
Spontaneous Mesotheliomas in Germline <i>Bap1</i> Heterozygous Mice from Different Genetic BackgroundsYuwaraj Kadariya, Li Zhang, Eleonora Sementino, et al.
Current Protocols|January 10, 2025
Modeling Malignant Mesothelioma in Genetically Engineered MiceYuwaraj Kadariya, Eleonora Sementino, Xiang Hua, et al.
Scientific Reports|September 28, 2020
Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesisYinfei Tan, Eleonora Sementino, Zemin Liu, et al.
Cancer Biology & Therapy|March 21, 2015
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 miceYinfei Tan, Eleonora Sementino, Jianming Pei, et al.
Cancers|November 26, 2022
Isolated <i>BAP1</i> Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic ResponseHatice Ulku Osmanbeyoglu, Drake Palmer, April Sagan, et al.
Data in Brief|November 25, 2022
Data supporting the roles of BAP1, STING, and IFN-β in ISGF3 activation in ccRCCLauren E Langbein, Eleonora Sementino, Zhijiu Zhong, et al.
Molecular and Cellular Biochemistry|June 5, 2010
Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathwaysLorena Urbanelli, Francesco Trivelli, Luisa Ercolani, et al.
Molecular Cancer Research : MCR|July 17, 2012
Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathwaysCraig W Menges, Eleonora Sementino, Jacqueline Talarchek, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Cancer Research|September 2, 2017
Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicityYinfei Tan, Eleonora Sementino, Jonathan Chernoff, et al.
Cancer Research|October 22, 2024
AKT and the Hallmarks of CancerEleonora Sementino, Dalal Hassan, Alfonso Bellacosa, et al.
Cancers|August 28, 2025
Spontaneous Mesotheliomas in Germline <i>Bap1</i> Heterozygous Mice from Different Genetic BackgroundsYuwaraj Kadariya, Li Zhang, Eleonora Sementino, et al.
Current Protocols|January 10, 2025
Modeling Malignant Mesothelioma in Genetically Engineered MiceYuwaraj Kadariya, Eleonora Sementino, Xiang Hua, et al.
Scientific Reports|September 28, 2020
Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesisYinfei Tan, Eleonora Sementino, Zemin Liu, et al.
Cancer Biology & Therapy|March 21, 2015
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 miceYinfei Tan, Eleonora Sementino, Jianming Pei, et al.
Cancers|November 26, 2022
Isolated <i>BAP1</i> Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic ResponseHatice Ulku Osmanbeyoglu, Drake Palmer, April Sagan, et al.
Data in Brief|November 25, 2022
Data supporting the roles of BAP1, STING, and IFN-β in ISGF3 activation in ccRCCLauren E Langbein, Eleonora Sementino, Zhijiu Zhong, et al.
Molecular and Cellular Biochemistry|June 5, 2010
Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathwaysLorena Urbanelli, Francesco Trivelli, Luisa Ercolani, et al.
Molecular Cancer Research : MCR|July 17, 2012
Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathwaysCraig W Menges, Eleonora Sementino, Jacqueline Talarchek, et al.
Pageof 3